Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
13 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/13/2945851/0/en/ONL-Therapeutics-Closes-65-Million-in-Oversubscribed-Series-D-Financing.html
10 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/10/2943524/0/en/ONL-Therapeutics-to-Present-at-the-57th-Annual-Scientific-Meeting-of-The-Retina-Society-and-EURETINA-Innovation-Spotlight.html
06 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/06/2824169/0/en/ONL-Therapeutics-to-Present-at-2024-BIO-CEO-Investor-Conference.html
23 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/23/2813952/0/en/ONL-Therapeutics-to-Present-on-ONL1204-in-Podium-Presentation-at-the-47th-Annual-Meeting-of-the-Macula-Society.html
28 Aug 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/08/28/2732482/0/en/ONL-Therapeutics-Completes-Enrollment-in-Phase-2-Study-of-First-in-Class-Fas-Inhibitor-in-Patients-with-Macula-Off-Rhegmatogenous-Retinal-Detachment.html
12 Apr 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/04/12/2645181/0/en/ONL-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-First-in-Class-Fas-Inhibitor-in-Patients-with-Macula-Off-Rhegmatogenous-Retinal-Detachment.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?